Page last updated: 2024-12-07

methionyl-leucyl-phenylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methionyl-leucyl-phenylalanine: RN given refers to all (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91672
CHEBI ID160871
SCHEMBL ID907360
MeSH IDM0124730

Synonyms (12)

Synonym
methionyl-leucyl-phenylalanine
CHEBI:160871
59881-08-2
(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid
met-leu-phe
l-methionyl-l-leucyl-l-phenylalanine
(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid
l-phenylalanine, n-(n-l-methionyl-l-leucyl)-
(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanyl-butanoyl]amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoic acid
SCHEMBL907360
DTXSID70975291
n-(2-{[2-amino-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-4-methylpentylidene)phenylalanine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (31.25)18.7374
1990's13 (27.08)18.2507
2000's5 (10.42)29.6817
2010's13 (27.08)24.3611
2020's2 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.46 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index21.45 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (4.17%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]